New myeloma meds work better than the old, but they're far too expensive: Report

New myeloma meds work better than the old, but they're far too expensive: Report

Submitted by admin on April 12, 2016 - 3:39pm
Source: 
Fierce Biotech
News Tags: 
Multiple Myeloma
Bristol-Myers Squibb
Amgen
Takeda
Empliciti
Kyprolis
Ninlaro
Celgene
Revlimid
Headline: 
New myeloma meds work better than the old, but they're far too expensive: Report

Do Not Allow Advertisers to Use My Personal information